Roopa Industries

Roopa Industries Total Assets

The Total Assets of Roopa Industries (530991.BO) as of Oct 28, 2026 is 719.60 M INR. In the previous year, Total Assets was 764.58 M INR — a change of -5.88% (lower).

Total Assets

719.60 MINR

YoY

-5.88%

Last updated:

Total Assets of Roopa Industries is 2026 719.60 M INR. Total Assets of Roopa Industries was 2025 764.58 M INR. It decreases by -5.88% lower compared to the previous year.

The Roopa Industries Total Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Total Assets
Date
Total Assets
Jan 1, 2019
364.66 M INR
Jan 1, 2020
381.91 M INR
Jan 1, 2021
463.31 M INR
Jan 1, 2022
490.25 M INR
Jan 1, 2023
565.49 M INR
Jan 1, 2024
646.79 M INR
Jan 1, 2025
764.58 M INR
Jan 1, 2026
719.60 M INR
The Roopa Industries Total Assets history
YEARTotal AssetsYoY
719.60 MINR-5.88%
764.58 MINR+18.21%
646.79 MINR+14.38%
565.49 MINR+15.35%
490.25 MINR+5.81%
463.31 MINR+21.31%
381.91 MINR+4.73%
364.66 MINR+3.24%
353.21 MINR+23.14%
286.83 MINR+13.54%
252.63 MINR-1.01%
255.21 MINR+6.96%
238.61 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Roopa Industries Stock analysis

What does Roopa Industries do? Roopa Industries Ltd. manufactures pharmaceutical products, focusing on bulk drugs and drug intermediates. The company produces N,N-dicyclohexylcarbodiimide (DCC), Triphenyl Phosphine (TPP), 5-Cyano Phthalide, Glucosamine, and Bromine And Its Derivatives. Triphenyl Phosphine is used by manufacturers of Cephalosporin antibiotics and Statins, while Bromine And Its Derivatives serve agrochemicals, dyes, medical and veterinary products, water purification, and pesticides. Glucosamine is a key nutraceutical product. The primary buyers include pharmaceutical manufacturers, agrochemical companies, and producers of medical and veterinary compounds. The company's revenue streams come from the sale of these specialized chemical products to industries requiring bulk drugs and intermediates. Triphenyl Phosphine supports antibiotic and statin production, making it essential for pharmaceutical firms. Bromine And Its Derivatives cater to diverse sectors like agriculture, water treatment, and disinfection, with significant demand from agrochemical and medical product manufacturers. Glucosamine, as a sheet anchor product, drives sales in the nutraceutical market. Roopa Industries targets the pharmaceutical, agrochemical, and medical sectors with its product portfolio. The firm's focus on bulk drugs and intermediates positions it as a supplier to manufacturers of antibiotics, statins, and nutraceuticals. Its products are integral to the production of Cephalosporin group antibiotics, Statins, and various agrochemical applications, ensuring consistent demand from established industrial buyers. Roopa Industries is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Roopa Industries stock

Total Assets of Roopa Industries is 719.60 M INR in 2026.

Total Assets of Roopa Industries changed from 764.58 M INR to 719.60 M INR, representing a -5.88% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Assets Roopa Industries since 2006 – with annual values, charts, and detailed analysis.

Total assets represent everything a company owns, including cash, inventory, property, and intangible assets. It is a key measure of a company's size and resource base.

Total Assets's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Assets's Roopa Industries historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Roopa Industries

All Key Metrics — Roopa Industries